Literature DB >> 15007808

A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization.

Sabine Fuchs1, Timo Kapp, Henning Otto, Torsten Schöneberg, Peter Franke, Ronald Gust, A Dieter Schlüter.   

Abstract

The synthesis, cytotoxicity, and behavior in cell culture of a new set of first- (G1) and second-generation (G2) dendrimers is reported. The surface functionality of these dendrimers has been varied to see whether structure/toxicity relations can be observed. The outermost functional groups are amines that are decorated either with protons, tert-butoxycarbonyl (Boc) or benzyloxycarbonyl (Cbz) protecting groups, Boc-protected or unprotected natural amino acid residues, ethylenediamine ligands, and/or dansyl fluorescence labels. The cytotoxicity was determined in vitro in concentration-dependent assays using the human MCF-7 breast cancer cell line. Cellular uptake and intracellular distribution was monitored by confocal fluorescence microscopy after internalization of the dansyl-labeled dendrimers by HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007808     DOI: 10.1002/chem.200305386

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  9 in total

1.  PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley rats.

Authors:  Orarat Wangpradit; Andrea Adamcakova-Dodd; Katharina Heitz; Larry Robertson; Peter S Thorne; Gregor Luthe
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-24       Impact factor: 4.223

2.  PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate.

Authors:  D Bhadra; S Bhadra; N K Jain
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

Review 3.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

4.  Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Bing Wang; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

5.  The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells.

Authors:  Jie Zhang; Dan Liu; Mengjun Zhang; Yuqi Sun; Xiaojun Zhang; Guannan Guan; Xiuli Zhao; Mingxi Qiao; Dawei Chen; Haiyang Hu
Journal:  Int J Nanomedicine       Date:  2016-08-03

6.  Synthesis of non-cytotoxic poly(ester-amine) dendrimers as potential solubility enhancers for drugs: methotrexate as a case study.

Authors:  Delia Soto-Castro; Jorge A Cruz-Morales; María Teresa Ramírez Apan; Patricia Guadarrama
Journal:  Molecules       Date:  2010-11-09       Impact factor: 4.411

7.  Design, synthesis and cytotoxic activity of water-soluble quinones with dibromo-p-benzoquinone cores and amino oligo(ethylene glycol) side chains against MCF-7 breast cancer cells.

Authors:  Leon F Scherz; Engy A Abdel-Rahman; Sameh S Ali; A Dieter Schlüter; Mona A Abdel-Rahman
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

Review 8.  Drug delivery approaches for breast cancer.

Authors:  Santosh Kumar Singh; Shriti Singh; James W Lillard; Rajesh Singh
Journal:  Int J Nanomedicine       Date:  2017-08-24

Review 9.  Cytotoxicity of Dendrimers.

Authors:  Anna Janaszewska; Joanna Lazniewska; Przemysław Trzepiński; Monika Marcinkowska; Barbara Klajnert-Maculewicz
Journal:  Biomolecules       Date:  2019-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.